The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index; 25 of the 53 sources its claims cite were checked for support.
The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel β-Secretase (BACE1) Substrate
Open accessAbstract
BACE is a transmembrane protease with beta-secretase activity that cleaves the amyloid precursor protein (APP). After BACE cleavage, APP becomes a substrate for gamma-secretase, leading to release of amyloid-beta peptide (Abeta), which accumulates in senile plaques in Alzheimer disease. APP and BACE are co-internalized from the cell surface to early endosomes. APP is also known to interact at the cell surface and be internalized by the low density lipoprotein receptor-related protein (LRP), a multifunctional endocytic and signaling receptor. Using a new fluorescence resonance energy transfer (FRET)-based assay of protein proximity, fluorescence lifetime imaging (FLIM), and co-immunoprecipitation we demonstrate that the light chain of LRP interacts with BACE on the cell surface in association with lipid rafts. Surprisingly, the BACE-LRP interaction leads to an increase in LRP C-terminal fragment, release of secreted LRP in the media and subsequent release of the LRP intracellular domain from the membrane. Taken together, these data suggest that there is a close interaction between BACE and LRP on the cell surface, and that LRP is a novel BACE substrate.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
BACE1 interacts with the intracellular domain of LRP at the cell surface in lipid rafts, and this interaction leads to BACE-mediated cleavage of LRP. The authors conclude that LRP is a novel BACE1 substrate, processed in a manner analogous to APP.
Key findings
- LRP and BACE co-immunoprecipitate: endogenous LRP light chain (~85 kDa) was pulled down with anti-BACE from human brain, and BACE bands (~60 and 75 kDa) were detected in mLRP1 immunoprecipitates from transfected H4 cells.
- FLIM/FRET showed close proximity: BACE-V5 FITC lifetime was 2334 ± 72 ps alone vs. 2153 ± 55 ps with mLRP1-Myc-Cy3 (p < 0.0001); mLRP1-GFP was 2164 ± 10 ps alone vs. 1165 ± 8 ps with BACE-V5-Cy3 (p < 0.0001); endogenous N2a BACE-CT Alexa 488 was 1868 ± 116 ps alone vs. 1492 ± 293 ps with 11H4-Cy3 (p < 0.0001).
- The interaction was weakened by cholesterol depletion (Myc-LC FITC + BACE-NT Cy3: 2023 ± 173 ps vs. 2203 ± 83 ps after depletion, p < 0.001), and an LC-LDLR chimera lacking the LRP intracellular domain did not FRET with BACE.
- BACE activity increased LRP ectodomain shedding and LRP C-terminal fragment/intracellular domain release: WT-BACE increased SEAP-LRP shedding, catalytically inactive BACE D93/289A had no effect, BACE inhibitor and BACE siRNA reduced cleavage, and BACE co-transfection increased a 25-kDa LRP-CTF and LRP-Gal4/VP16 luciferase activity.
Methods
- Cell systems included H4, mouse neuroblastoma N2a, pac1, LRP-deficient CHO 13-5-1, HEK293, and primary cortical neurons from embryonic day 16 CD1 mice; constructs included Myc-LC, mLRP1-Myc, mLRP1-GFP, LRP165-Myc, LC-LDLR, SEAP-LRP, LRP-Gal4-VP16, BACE-V5/Myc/GFP, and BACE mutants.
- Protein interaction and localization were assessed by co-immunoprecipitation, immunocytochemistry/confocal microscopy, caveolae/noncaveolae fractionation, cholesterol depletion, human temporal cortex staining, and FLIM-based FRET.
- Functional processing was assayed by BACE internalization assays in LRP-null cells, SEAP-LRP ectodomain secretion, Western blotting for LRP-CTF with DAPT, and luciferase reporter assay for LRP-ICD release; statistics used Student’s t test.
Limitations
- Stated: whether LRP processing produces a stable LRP equivalent of Aβ is unknown; whether LRP-ICD has a transcriptional role under physiological conditions remains unknown; further studies are needed to determine if APP and LRP act co-operatively or competitively for secretase access and how LRP ligands affect these processes.
- Stated: Fe65 and mDab1 did not appear to mediate the BACE-LRP interaction under the conditions used, though multiple other adaptor proteins might mediate or impact it.
- Evident from the text: many interaction, shedding, CTF, and ICD experiments rely on transfected constructs and overexpression in cell lines; endogenous validation is limited to co-immunoprecipitation and FLIM in N2a cells, primary neurons, and human brain, with no in vivo causal test of LRP cleavage or downstream signaling.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
25 of 53 cited sources checked · 12 supported · 0 flagged · accuracy not yet measured
Every source the paper cites for this claim was checked and supports it.
In the paper
“Thus, LRP, which is highly enriched in rafts, potentially acts as a scaffolding complex in rafts for APP and for BACE; such an interaction may help explain the observations that directing APP to rafts enhances -cleavage and A generation (13).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > FIG. 9. BACE increases release of LRP-ICD.
What the sources say
- Supportedcites [13] Ehehalt, 2003, J. Cell Biol. source
The citation is attached to the observation about raft-directed APP processing, not to the citing authors’ proposed LRP scaffold. The Results report that copatching APP and BACE1 increased Aβ secretion, and the Discussion’s Figure 8 model links their raft clustering to β-cleavage. The paper does not establish the proposed role for LRP. (LLM, conf=0.88)
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Rests on an assumption: LRP is highly enriched in lipid rafts.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Immunoreactive bands of ϳ100 kDa (resembling mature furin-cleaved mLRP1-Myc) and ϳ140 kDa (resembling unprocessed Golgi and ER forms of mLRP1-Myc) (29) were detected in the immunoprecipitated sample and the whole cell lysate (Fig. 3A, lane 4).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Localization of BACE and LRP Constructs-We first tested the localization of BACE and LRP in co-expressing H4 cells.
What the sources say
- Partly supportedcites [29] Mikhailenko, 2001, J. Biol. Chem. sourceExperimental — accuracy not yet measured
The passage headed “High Affinity α2M* Binding to LRP Requires Ligand Binding Repeats in Both Cluster I and Cluster II” (page unavailable) reports that Myc-tagged mini-receptors, including mLRP1, were processed by furin. It does not identify approximately 100-kDa and 140-kDa bands as mature and unprocessed mLRP1-Myc forms. The BACE immunoprecipitation is presented as the citing paper’s own result, not as a result attributed to this source. (LLM, conf=0.83)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Co-transfection with LC did not enhance BACE internalization from the cell surface in LRP-null CHO cells (13-5-1) in contrast to known enhancement of APP endocytosis with LC (20).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > BACE Internalization Assay-Because
What the sources say
- Supportedcites [20] Pietrzik, 2002, EMBO J. source
The citation is attached to the contrast about APP endocytosis, not the citing authors’ BACE result. In “Abnormalities in APP processing are isoform independent” (Fig. 6A; page unavailable), the paper reports that introducing LRP-CT largely restored APP internalization in LRP-deficient fibroblasts. (LLM, conf=0.90)
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“However, both LRP (48,49) and other members of the LDL receptor-related family (50) have been implicated as having signaling roles in neurons, and it seems likely that the cleavage of LRP we observe could modulate such signaling.”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > FIG. 9. BACE increases release of LRP-ICD.
What the sources say
- Supportedcites [48] Bacskai, 2000, Proc. Natl. Acad. Sci. U. S. A. source
The Discussion reports that LRP serves as a neuronal signaling receptor: stimulation through LRP elicits a calcium response. The suggestion that the citing authors’ observed cleavage could modulate that signaling is their own inference, not a finding attributed to this source. (LLM, conf=0.93)
- Not checked — no full text of the sourcecites [49] Boucher, 2002, J. Biol. Chem. source
- Supportedcites [50] Trommsdorff, 1999, Cell source
The cited paper supports the statement attached to citation 50: its Abstract reports signaling functions for VLDLR and ApoER2, members of the LDL receptor family, in neuronal migration. Its Discussion likewise describes a role for the family in cellular signaling beyond ligand endocytosis. The suggestion that LRP cleavage could modulate signaling is the citing authors’ own inference, not a finding attributed to this source. (LLM, conf=0.93)
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Co-transfection with BACE led to a substantial increase in luciferase activity suggesting that LRP undergoes BACE cleavage, leading ultimately to release of the cytoplasmic domain and translocation to the nucleus (Fig. 9).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > BACE Internalization Assay-Because
What the sources say
- Could not verifycites [28] May, 2002, J. Biol. Chem. sourceExperimental — accuracy not yet measured
The Results describe an LRP-Gal4/VP16 luciferase assay, but do not report BACE co-transfection. A search for BACE found only a Discussion passage about β-secretase cleavage of APP, not an effect of BACE on LRP reporter activity. (LLM, conf=0.76)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Could not verify
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This led to an increase of LRP-CTF detected by Western blot as a 25-kDa band.”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > BACE Internalization Assay-Because
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Rests on an assumption: The 25-kDa band detected by Western blot is LRP-CTF.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Surprisingly, the BACE-LRP interaction leads to an increase in LRP C-terminal fragment, release of secreted LRP in the media and subsequent release of the LRP intracellular domain from the membrane.”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“To confirm that this band is the substrate of ␥-secretase activity, we repeated this experiment in the presence of the ␥-secretase inhibitor DAPT, and detected an increased amount of the 25-kDa product.”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > BACE Internalization Assay-Because
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Rests on an assumption: The 25-kDa band detected by Western blot is LRP-CTF.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“By staining human brain sections, includ-ing the hippocampal formation, we were able to observe similar results in neurons expressing endogenous levels of LRP and BACE (Fig. 3D).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Localization of BACE and LRP Constructs-We first tested the localization of BACE and LRP in co-expressing H4 cells.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“WT-BACE led to a significant increase in LRP ectodomain shedding compared with baseline, whereas, as expected, catalytically inactive BACE D93/289A exhibited no effect (Fig. 7A).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > BACE Internalization Assay-Because
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Rests on an assumption: BACE D93/289A is catalytically inactive.
- Probably not a substantial claim. 26
- It may state two separate claims as one. 29
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Multiple intracellular adaptor and scaffolding proteins bind the LRP 100 amino acid cytoplasmic tail (16,17);”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Abstract
What the sources say
- Partly supportedcites [16] Herz, 2001, J. Clin. Investig. sourceExperimental — accuracy not yet measured
The sections “Interactions with intracellular adapter and scaffold proteins” and “Structural organization of LRP” state that multiple cytoplasmic adaptor and scaffold proteins interact with the LRP tail. Our copy does not specify that the tail is 100 amino acids long, so that numerical detail is unsupported. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [17] Li, 2001, Mol. Neurobiol. source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Furthermore, and as with APP, ␥-secretase cleavage of LRP leads to release of the LRP intracellular domain (LRP-ICD), which can translocate to the nucleus and interact with Tip60 (27,28).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Abstract
What the sources say
- Partly supportedcites [27] Kinoshita, 2003, J. Biol. Chem. sourceExperimental — accuracy not yet measured
The Discussion says LRP cleavage releases its intracellular domain, which translocates to the nucleus; Fig. 5 reports close interaction with Tip60 there. The Discussion describes γ-secretase as the probable cause of cleavage, so the citing sentence states that mechanism more definitively than the source does. Page numbers are unavailable in our copy. (LLM, conf=0.85)
- Partly supportedcites [28] May, 2002, J. Biol. Chem. sourceExperimental — accuracy not yet measured
The Abstract reports release of the LRP intracellular domain by a γ-secretase-like activity, and the paper says FE65 can promote its nuclear translocation under certain conditions. It does not establish an LRP-ICD interaction with Tip60: a later passage (indexed as Abstract; page unavailable) raises the possibility that FE65 binding to LRP and recruitment of Tip60 are mutually exclusive, and its reporter assay did not show Tip60-dependent activity. (LLM, conf=0.90)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“proteolysis of LRP by matrix metalloproteases was recently reported (25);”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Abstract
What the sources say
- Supportedcites [25] Rozanov, 2004, J. Biol. Chem. source
The Results report that MT1-MMP proteolyzed LRP and that MT2-MMP, MT3-MMP, and MT4-MMP also degraded it in vitro. The Discussion likewise identifies these matrix metalloproteinases as capable of cleaving LRP. (LLM, conf=0.94)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In addition, an interaction between the C-terminal domain of APP and LRP, mediated by the cytoplasmic adaptor protein Fe65, impacts APP internalization (18 -23).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Abstract
What the sources say
- Not checked — no full text of the sourcecites [18] Kounnas, 1995, Cell source
- Partly supportedcites [19] Ulery, 2000, J. Biol. Chem. sourceExperimental — accuracy not yet measured
The discussion (page unavailable in our copy) says Fe65 binds the cytoplasmic portions of APP and LRP and may link them. It also proposes that APP–LRP interaction modulates APP trafficking through the endocytic pathway. It does not establish that Fe65 mediates an interaction that impacts APP internalization; that mechanism remains a possibility rather than a demonstrated finding. (LLM, conf=0.85)
- Partly supportedcites [20] Pietrzik, 2002, EMBO J. sourceExperimental — accuracy not yet measured
In “Abnormalities in APP processing are isoform independent” (page not given), the paper reports reduced APP internalization without LRP and its restoration by an LRP C-terminal construct. The Discussion (page not given) proposes an adaptor linking APP and LRP but says whether adaptors coordinate their internalization awaits further study. It mentions Fe65 in connection with transcription, not as an established mediator of APP internalization. (LLM, conf=0.87)
- Not checked — no full text of the sourcecites [21] Rebeck, 2001, Brain Res. Mol. Brain Res. source
- Not checked yetcites [22] Kinoshita, 2001, J. Neurosci. source
Checked before — its earlier verdict is held back until a new check runs.
- Partly supportedcites [23] Trommsdorff, 1998, J. Biol. Chem. sourceExperimental — accuracy not yet measured
The Results show that distinct FE65 domains bind the cytoplasmic tails of LRP and APP, and the Discussion says FE65 could in principle link them. The paper proposes that this might affect APP trafficking or receptor endocytosis, but does not demonstrate an effect on APP internalization; its conclusion says that physiological relevance for endocytosis remains to be tested. (LLM, conf=0.90)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“its four extracellular binding domains mediate endocytosis of a wide array of ligands, including several of potential importance for Alzheimer disease pathophysiology: APP, apolipoprotein E and ␣ 2 -macroglobulin (16 -18).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Abstract
What the sources say
- Supportedcites [16] Herz, 2001, J. Clin. Investig. source
The Structural organization of LRP section describes four clusters of extracellular ligand-binding repeats and their role in ligand internalization. The Potential roles in Alzheimer disease section states that LRP serves as a receptor for APP, apoE, and α2-macroglobulin; Table 1 lists all three among ligands binding its extracellular domain. No page numbers are available in our copy. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [17] Li, 2001, Mol. Neurobiol. source
- Not checked — no full text of the sourcecites [18] Kounnas, 1995, Cell source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“BACE and APP are internalized from the cell surface to early endosomes and cycle between the cell membrane and endosomes (10,11,15).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Abstract
What the sources say
- Not checked — no full text of the sourcecites [10] Kinoshita, 2003, J. Cell Sci. source
- Not checked — no full text of the sourcecites [11] Huse, 2000, J. Biol. Chem. source
- Partly supportedcites [15] Walter, 2001, J. Biol. Chem. sourceExperimental — accuracy not yet measured
The introduction says BACE moves from the cell surface to early endosomes and can recycle to the surface; the trafficking results also show BACE entering early endosomes. The paper reports APP colocalization with BACE, but the passages do not establish that APP follows the same internalization and recycling route. (LLM, conf=0.87)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
Every source the paper cites for this claim was checked and supports it.
In the paper
“A family of GGA adaptor proteins and the phospholipid scramblase 1 (PLSCR1) have been shown to directly interact with the BACE tail (42,45).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > DISCUSSION
What the sources say
- Supportedcites [42] He, 2002, FEBS Lett. source
The Introduction and Discussion report that the C-terminal region of memapsin 2 (BACE) binds the VHS domains of GGA1 and GGA2. This supports the GGA interaction attributed to this paper; the sentence has a second citation for the separate PLSCR1 claim. (LLM, conf=0.92)
- Supportedcites [45] Kametaka, 2003, J. Biol. Chem. source
The Results report that PLSCR1 interacts with the BACE tail in yeast two-hybrid and in vitro binding assays. The Discussion states that GGA adaptor proteins have also been shown to directly interact with the BACE tail. (LLM, conf=0.92)
Strength:boosted· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Co-transfection with BACE led to a substantial increase in luciferase activity suggesting that LRP undergoes BACE cleavage, leading ultimately to release of the cytoplasmic domain and translocation to the nucleus (Fig. 9).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > BACE Internalization Assay-Because
What the sources say
- Partly supportedcites [28] May, 2002, J. Biol. Chem. sourceExperimental — accuracy not yet measured
The paper reports release of LRP’s cytoplasmic domain and, in the Abstract, says FE65 can stimulate its translocation into the nucleus under certain conditions. It does not establish BACE cleavage as the initiating step; the Discussion instead identifies furin and metalloproteinase cleavage and implicates a γ-secretase-like activity in tail release. The citing sentence’s BACE co-transfection result is its own finding, not a result attributed to this source. (LLM, conf=0.88)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Besides APP, the few BACE substrates that have been identi-fied include the APP homologues APLP1 and -2 (5), P-selectin glycoprotein ligand-1 (PSGL-1), and a membrane-bound sialyltransferase (6).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Abstract
What the sources say
- Supportedcites [5] Li, 2004, J. Biol. Chem. source
The citation to this paper is attached specifically to APLP1 and APLP2, not to PSGL-1 or the sialyltransferase. The Discussion states that BACE 1 cleaves both APLP1 and APLP2 and summarizes the experimental evidence. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [6] Kitazume, 2001, Proc. Natl. Acad. Sci. U. S. A. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Although LRP-ICD has been shown to translocate to the nucleus and interact with Fe65 and Tip60 (28,47), whether or not it has a transcriptional role under physiological conditions remains unknown.”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > FIG. 9. BACE increases release of LRP-ICD.
What the sources say
- Partly supportedcites [28] May, 2002, J. Biol. Chem. sourceExperimental — accuracy not yet measured
The Abstract says that FE65 can stimulate translocation of the LRP tail fragment into the nucleus under certain conditions, and the Discussion says LRP binds FE65. But the Discussion (Fig. 6C) suggests that FE65 binding to the LRP tail and binding to Tip60 are mutually exclusive; it does not show LRP-ICD interacting with Tip60. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Could not verifycites [47] Kinoshita, 2002, J. Biol. Chem. sourceExperimental — accuracy not yet measured
The Results and Discussion describe APP-CT, not LRP-ICD, translocating to the nucleus and interacting with Fe65 and Tip60; no page numbers are available in our copy. Searches for LRP-ICD, its expanded name, and LRP found no passage addressing whether LRP-ICD does so. (LLM, conf=0.77)
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“However, both LRP (48,49) and other members of the LDL receptor-related family (50) have been implicated as having signaling roles in neurons, and it seems likely that the cleavage of LRP we observe could modulate such signaling.”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > FIG. 9. BACE increases release of LRP-ICD.
What the sources say
- Supportedcites [48] Bacskai, 2000, Proc. Natl. Acad. Sci. U. S. A. source
The citation to this paper is attached to LRP’s signaling role, not the separate claim about other family members or the authors’ suggestion about cleavage. The paper’s Discussion reports that stimulation through LRP elicits a calcium response in neurons and concludes that LRP also serves as a signaling receptor. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [49] Boucher, 2002, J. Biol. Chem. source
- Supportedcites [50] Trommsdorff, 1999, Cell source
The Abstract identifies VLDLR and ApoER2 as LDL receptor family members with signaling functions in the Reelin pathway. The Discussion likewise describes their role in neuronal migration signaling. This supports the portion of the sentence attributed to citation 50; the separate claims about LRP and its cleavage are not attributed to this source. (LLM, conf=0.93)
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Because LRP is a known ␥-substrate, we hypothesized that it might also be cleaved by -secretase.”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > BACE Internalization Assay-Because
What the sources say
- Supportedcites [28] May, 2002, J. Biol. Chem. source
The Abstract reports that LRP’s cytoplasmic domain is released by a γ-secretase-like activity. The Discussion reports that γ-secretase inhibitors strongly inhibited LRP tail cleavage, supporting the description of LRP as a γ-secretase substrate. (LLM, conf=0.90)
Load-bearingStrength:boosted· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“such an interaction may help explain the observations that directing APP to rafts enhances -cleavage and A generation (13).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > FIG. 9. BACE increases release of LRP-ICD.
What the sources say
- Partly supportedcites [13] Ehehalt, 2003, J. Cell Biol. sourceExperimental — accuracy not yet measured
The Results section on antibody-induced cross-linking (page not provided) reports increased Aβ secretion when APP and BACE1 were copatched in rafts. The Discussion says this clustering can promote β-cleavage, but also states that partitioning APP and BACE1 into rafts alone is insufficient: cleavage normally depends on endocytosis. The claim omits that distinction and implies that directing APP to rafts by itself produces both effects. (LLM, conf=0.85)
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“LC, which contains the -chain of LRP, and LRP165, a construct that contains only the 100 amino acid intracellular domain, the transmembrane domain and a very small extension beyond the membrane, both interacted strongly with BACE (Table I).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Localization of BACE and LRP Constructs-We first tested the localization of BACE and LRP in co-expressing H4 cells.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: FRET requires the two fluorophores to be within less than 10 nm of each other.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“FITC bound to BACE-V5 in the absence of acceptor has a uniform lifetime and a single lifetime peak (Fig. 4A);”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Localization of BACE and LRP Constructs-We first tested the localization of BACE and LRP in co-expressing H4 cells.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The presence of BACE further increased and co-transfection with catalytically inactive BACE mutant did not increase this band intensity (Fig. 8).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > BACE Internalization Assay-Because
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: BACE D93/289A is catalytically inactive.
- Rests on an assumption: The 25-kDa band detected by Western blot is LRP-CTF.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The doublet bands of ϳ60 and 75 kDa were detected only in lane 1 and in the control lysate lane (Fig. 3B), suggesting that BACE is present in the mLRP1 immunoprecipitates.”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Localization of BACE and LRP Constructs-We first tested the localization of BACE and LRP in co-expressing H4 cells.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Co-localization and close proximity in both H4 and N2a cells was shown by confocal microscopy and FRET-based proximity assays, suggesting co-localization primarily in endosomes and at the cell surface.”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > DISCUSSION
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: FRET requires the two fluorophores to be within less than 10 nm of each other.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Although there was striking co-localization, no lifetime change was observed.”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Localization of BACE and LRP Constructs-We first tested the localization of BACE and LRP in co-expressing H4 cells.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in the presence of mLRP1-Cy3 acceptor, FITC has two distinct lifetimes and is faster, representing “FRETting” molecules (Fig. 4B).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Localization of BACE and LRP Constructs-We first tested the localization of BACE and LRP in co-expressing H4 cells.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the absence of an acceptor fluorophore, the lifetime of FITC conjugated to IgG (hereafter referred to simply as FITC) is ϳ2300 ps, GFP ϳ2200 ps, and Alexa 488 is ϳ1900 ps.”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Localization of BACE and LRP Constructs-We first tested the localization of BACE and LRP in co-expressing H4 cells.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, under the conditions utilized we did not detect any FRET between BACE and Fe65 or between BACE and mDab1 (data not shown).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Localization of BACE and LRP Constructs-We first tested the localization of BACE and LRP in co-expressing H4 cells.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: FRET requires the two fluorophores to be within less than 10 nm of each other.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The interaction was demonstrated by co-immunoprecipitation of BACE and LRP from overexpressing cells and from endogenous BACE and LRP in human brain samples and primary neurons.”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > DISCUSSION
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The lifetime of FITC attached to the C terminus of BACE-V5 alone (2334 Ϯ 72 ps) was significantly shortened when co-expressed mLRP1-Myc was C-terminally labeled by Cy3 (2153 Ϯ 55 ps, p Ͻ 0.0001), indicating FRET between the two fluorophores (Table I).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Localization of BACE and LRP Constructs-We first tested the localization of BACE and LRP in co-expressing H4 cells.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found that BACE activity at endogenous levels leads to an increase of secreted LRP in the medium as well as LRP-CTF, analogous to APP processing.”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > FIG. 9. BACE increases release of LRP-ICD.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The low density lipoprotein receptor-related protein, LRP, is a type I integral membrane protein with a 515-kDa extracellular ␣-chain non-convalently bound to the 85 kDa membranespanning -chain.”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Abstract
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“No bleedthrough or mis-excitation of Cy3 was observed under these conditions.”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Generation of Expression Constructs of LRP and BACE and BACE
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“BACE is a transmembrane protease with -secretase activity that cleaves the amyloid precursor protein (APP).”
- Also stated in: § Abstract · plain
“BACE 1 ( site of APP-cleaving enzyme) is a type I membrane-associated aspartyl protease that cleaves APP (1)(2)(3)(4).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Abstract
What the sources say
- Not matchedcites (1)(2)(3)(4)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Also stated in: § Abstract · plain
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Specific knockdown of Ͼ70% of overexpressing BACE was observed starting 24 h after transfection by Western blot and immunostaining (data not shown).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Generation of Expression Constructs of LRP and BACE and BACE
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“In contrast to ␥-secretase, where at least 15 substrates have been described (44), BACE has so far appeared to be relatively specific.”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > DISCUSSION
What the sources say
- Not checked — no full text of the sourcecites [44] De Strooper, 2003, Neuron source
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Measurable amounts of APP and BACE are present on the plasma membrane (10 -12) and in lipid rafts (12)(13)(14).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Abstract
What the sources say
- Not checked — no full text of the sourcecites [10] Kinoshita, 2003, J. Cell Sci. source
- Not checked — no full text of the sourcecites [11] Huse, 2000, J. Biol. Chem. source
- Not checked — no full text of the sourcecites [12] Riddell, 2001, Curr. Biol. source
- Not matchedcites (12)(13)(14)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“MT1-MMP also cleaves APP (26)”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Abstract
What the sources say
- Not checked — no full text of the sourcecites [26] Higashi, 2003, Biochemistry source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“indicating that the observed effect has physiologic relevance and is not restricted to cells overexpressing BACE (Fig. 7B).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > BACE Internalization Assay-Because
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The 60-kDa band represents endogenous BACE, whereas the 75-kDa band represents transfected BACE containing a V5-His tag.”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Localization of BACE and LRP Constructs-We first tested the localization of BACE and LRP in co-expressing H4 cells.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Post-translational processing of BACE involves N-glycosylation, removal of its prodomain by a furin-like protease, and further complex glycosylation (7)(8)(9).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Abstract
What the sources say
- Not matchedcites (7)(8)(9)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Not matched
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“It is also found on the cell surface and cycles between the cell membrane and endosomes.”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Abstract
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Examination of the FLIM images of transfected cells suggests that LRP and BACE interact (red pseudocolor) at the cell surface and in endosomal compartments.”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Localization of BACE and LRP Constructs-We first tested the localization of BACE and LRP in co-expressing H4 cells.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Ectodomain shedding of LRP has been described (24)”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Abstract
What the sources say
- Not checked — no full text of the sourcecites [24] Quinn, 1999, Exp. Cell Res. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Authenticity of the PCRgenerated constructs was confirmed by sequencing.”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Generation of Expression Constructs of LRP and BACE and BACE
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus we now show that LRP is a substrate for both BACE and ␥-secretase, identified as APP-processing enzymes.”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > FIG. 9. BACE increases release of LRP-ICD.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: BACE D93/289A is catalytically inactive.
- Rests on an assumption: BACE1-specific siRNA specifically knocks down BACE.
- Rests on an assumption: The 25-kDa band detected by Western blot is LRP-CTF.
None of the sources cited for this claim have been checked yet.
In the paper
“After glycosylation, BACE co-traffics with APP and is rapidly transported to the Golgi apparatus and distal secretory pathway (9).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Abstract
What the sources say
- Not checked yetcites [9] Creemers, 2001, J. Biol. Chem. source
Checked before — its earlier verdict is held back until a new check runs.
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Not checked yet
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Control precipitate from samples lacking anti-BACE Ab (lane 2) showed only a weak immunoreactive band, and samples lacking cell extract (lane 3) did not contain this band.”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > Localization of BACE and LRP Constructs-We first tested the localization of BACE and LRP in co-expressing H4 cells.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Sialyltransferase and PSGL-1, in addition to APP and its homologues APLP1 and 2 are the only other reported substrates of BACE (6,43).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > DISCUSSION
What the sources say
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“This is in good accordance with a recent article showing that ApoE, a LRP ligand, is co-localized with APP and BACE in lipid rafts (46).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > FIG. 9. BACE increases release of LRP-ICD.
What the sources say
- Not checked yetcites [46] Kawarabayashi, 2004, J. Neurosci. source
Checked before — its earlier verdict is held back until a new check runs.
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Not checked yet
None of the sources cited for this claim have been checked yet.
In the paper
“The LRP C-terminal domain also mediates an interaction with APP in similar cell compartments (22).”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > FIG. 9. BACE increases release of LRP-ICD.
What the sources say
- Not checked yetcites [22] Kinoshita, 2001, J. Neurosci. source
Checked before — its earlier verdict is held back until a new check runs.
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Not checked yet
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Analogous results were obtained using three different fluorophores, multiple different antibody pairs, endogenous or transfected LRP and BACE, and two different cell types.”
§ The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel -Secretase (BACE1) Substrate* > DISCUSSION
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper relies on this without support.
The mLRP1 and Myc-LC constructs are functionally similar to full-length LRP.
“These constructs were used instead of full-length LRP because of its functional similarity to and better expression than full-length LRP.”
The paper relies on this without support.
BACE directly cleaves LRP.
“LRP is a novel BACE substrate.”
“BACE induces LRP extracellular domain cleavage”
The paper relies on this without support.
Cholesterol depletion with lovastatin/mevalonate and MβCD disrupts lipid rafts.
“To test the hypothesis that this interaction occurs in rafts we cholesterol depleted the cells and repeated the cell surface FLIM experiment.”
“Cholesterol depletion was performed with lovastatin/mevalonate for 24 h and MCD for 10 min.”
The authors state this as an assumption.
FRET requires the two fluorophores to be within less than 10 nm of each other.
“The two fluoro-phores must be quite close (Ͻ10 nm) to support FRET; tagging LRP and BACE molecules “across the membrane” from one another or after cholesterol depletion abolishes FRET despite continued co-localization at the light level.”
The paper relies on this without support.
LRP is highly enriched in lipid rafts.
“Thus, LRP, which is highly enriched in rafts, potentially acts as a scaffolding complex in rafts for APP and for BACE; such an interaction may help explain the observations that directing APP to rafts enhances -cleavage and A generation (13).”
The paper relies on this without support.
BACE D93/289A is catalytically inactive.
“WT-BACE led to a significant increase in LRP ectodomain shedding compared with baseline, whereas, as expected, catalytically inactive BACE D93/289A exhibited no effect (Fig. 7A).”
The paper relies on this without support.
BACE1-specific siRNA specifically knocks down BACE.
“Knocking down overexpressed BACE by co-transfection of BACE1-specific siRNA reduced processing of LRP by BACE (Fig. 7C).”
The paper relies on this without support.
The 25-kDa band detected by Western blot is LRP-CTF.
“This led to an increase of LRP-CTF detected by Western blot as a 25-kDa band.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Whole-cell lysate assigned to conflicting lanes
MinorThe results text places the whole-cell lysate for Figure 3A in lane 4, but the Figure 3A caption identifies lane 5 as the positive-control lysate.
“were detected in the immunoprecipitated sample and the whole cell lysate (Fig. 3A, lane 4).”
“Anti-Myc recognizes precursor endoplasmic reticulum and Golgi forms (labeled p) as well as -chains of mature proteins (labeled b) (positive control, lane 5) (29).”
Citations
Cites
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Purification and cloning of amyloid precursor protein β-secretase from human brain
Sinha, S., Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., Doan, M., Dovey, H. F., Frigon, N., Hong, J., et al. (1999) · Nature · doi:10.1038/990114 · Cited by 1,612
Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity
Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., Pauley, A. M., Brashler, J. R., Stratman, N. C., Mathews, W. R., Buhl, A. E., et al. (1999) · Nature · doi:10.1038/990107 · Cited by 1,438
Trommsdorff, M., Gotthardt, M., Hiesberger, T., Shelton, J., Stockinger, W., Nimpf, J., Hammer, R. E., Richardson, J. A., & Herz, J. (1999) · Cell · doi:10.1016/s0092-8674(00)80782-5 · Cited by 1,261
Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase
Hussain, I., Powell, D., Howlett, D. R., Tew, D. G., Meek, T. D., Chapman, C., Gloger, I. S., Murphy, K. E., Southan, C. D., Ryan, D. M., et al. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0811 · Cited by 1,080
Aph-1, Pen-2, and Nicastrin with Presenilin Generate an Active γ-Secretase Complex
De Strooper, B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00205-8 · Cited by 965
Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts
Ehehalt, R., Keller, P., Haass, C., Thiele, C., & Simons, K. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200207113 · Cited by 932
LRP: a multifunctional scavenger and signaling receptor
Herz, J., & Strickland, D. K. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13992 · Cited by 908
Self-citationLRP: a multifunctional scavenger and signaling receptor
Herz, J., & Strickland, D. K. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113992 · Cited by 908
Self-citationA detergent-free method for purifying caveolae membrane from tissue culture cells.
Smart, E. J., Ying, Y. S., Mineo, C., & Anderson, R. G. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.22.10104 · Cited by 728
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 258
Gaultier, A., Arandjelovic, S., Li, X., Janes, J. R., Dragojlovic, N., Zhou, G. P., Dolkas, J., Myers, R. R., Gonias, S. L., & Campana, W. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32371 · Cited by 68
APP Processing and the APP-KPI Domain Involvement in the Amyloid Cascade
Menéndez‐González, M., Pérez‐Piñera, P., Martínez-Rivera, M., Calatayud, M. T. R., & Menes, B. B. (2005) · Neurodegenerative Diseases · doi:10.1159/000092315 · Cited by 68
Auderset, L., Cullen, C. L., & Young, K. M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0155878 · Cited by 62
The structure and function of Alzheimer’s gamma secretase enzyme complex
Krishnaswamy, S., Verdile, G., Groth, D., Kanyenda, L. J., & Martins, R. N. (2009) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408360903335821 · Cited by 65
Increased BACE1 maturation contributes to the pathogenesis of Alzheimer's disease in Down syndrome
Sun, X., Tong, Y., Qing, H., Chen, C.-H., & Song, W. (2006) · The FASEB Journal · doi:10.1096/fj.05-5628com · Cited by 64
Regulation of LRP-1 expression: Make the point
Emonard, H., Théret, L., Bennasroune, A. H., & Dedieu, S. (2014) · Pathologie Biologie · doi:10.1016/j.patbio.2014.02.002 · Cited by 53
Impact of cholesterol level upon APP and BACE proximity and APP cleavage
Arnim, C. A. F. V., von Einem, B., Weber, P., Wagner, M., Schwanzar, D., Spoelgen, R., Strauß, W. S. L., & Schneckenburger, H. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.03.047 · Cited by 63
Self-citationMihailovich, M., Thermann, R., Grohovaz, F., Hentze, M. W., & Zacchetti, D. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm191 · Cited by 63
Toh, W. H., & Gleeson, P. A. (2016) · Biochemical Journal · doi:10.1042/bcj20160147 · Cited by 62
LRP4 in neuromuscular junction and bone development and diseases
Shen, C., Xiong, W., & Mei, L. (2015) · Bone · doi:10.1016/j.bone.2015.05.012 · Cited by 61
LRP1 modulates APP trafficking along early compartments of the secretory pathway
Waldron, E., Heilig, C., Schweitzer, A., Nadella, N., Jaeger, S., Martin, A. M., Weggen, S., Brix, K., & Pietrzik, C. U. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.04.006 · Cited by 61
Sink Hypothesis and Therapeutic Strategies for Attenuating Aβ Levels
Zhang, Y., & Lee, D. H. S. (2011) · The Neuroscientist · doi:10.1177/1073858410381532 · Cited by 61
Protease inhibitors as potential disease-modifying therapeutics for Alzheimer’s disease
Beher, D., & Graham, S. L. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.11.1385 · Cited by 61
Physiological functions of the amyloid precursor protein secretases ADAM10, BACE1, and Presenilin
Prox, J., Rittger, A., & Säftig, P. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2952-0 · Cited by 60
BACE1 as a Therapeutic Target in Alzheimer’s Disease: Rationale and Current Status
Evin, G. M., & Hince, C. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0099-3 · Cited by 60
Selvais, C., Gaide Chevronnay, H. P., Lemoine, P., Dedieu, S., Henriet, P., Courtoy, P. J., Marbaix, E., & Emonard, H. (2009) · Endocrinology · doi:10.1210/en.2009-0015 · Cited by 54
Sugimoto, I., Futakawa, S., Oka, R., Ogawa, K., Marth, J. D., Miyoshi, E., Taniguchi, N., Hashimoto, Y., & Kitazume, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704766200 · Cited by 59
Brifault, C., Gilder, A. S., Laudati, E., Banki, M. A., & Gonias, S. L. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.798413 · Cited by 58
Chakraborty, M., Lou, C., Huan, C., Kuo, M., Park, T., Cao, G., & Jiang, X. (2013) · Journal of Clinical Investigation · doi:10.1172/jci60415 · Cited by 57
The Normal and Pathologic Roles of the Alzheimer's β-secretase, BACE1
Kandalepas, P. C., & Vassar, R. J. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666140604122059 · Cited by 56
Potential Enzymatic Targets in Alzheimer’s: A Comprehensive Review
Alam, J., & Sharma, L. K. (2018) · Current Drug Targets · doi:10.2174/1389450119666180820104723 · Cited by 56
Lipoprotein receptors in Alzheimer's disease
Andersen, O. M., & Willnow, T. E. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.09.002 · Cited by 41
Derocq, D., Prébois, C., Beaujouin, M., Laurent‐Matha, V., Pattingre, S., Smith, G. K., & Liaudet‐Coopman, E. (2011) · Oncogene · doi:10.1038/onc.2011.501 · Cited by 53
FRET analysis of domain formation and properties in complex membrane systems
Loura, L. M. S., de Almeida, R. F. M., Silva, L. C., & PRIETO, M. J. E. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.10.012 · Cited by 52
Alzheimer's Therapeutics: Translation of Preclinical Science to Clinical Drug Development
Savonenko, A. V., Melnikova, T., Hiatt, A., Li, T., Worley, P. F., Troncoso, J. C., Wong, P. C., & Price, D. L. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.211 · Cited by 52
Pathogenic mechanisms in Alzheimer's disease
Pastorino, L., & Lu, K. P. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.078 · Cited by 52
Mori, T., Koyama, N., Segawa, T., Maeda, M., Maruyama, N., Kinoshita, N., Hou, H., Tan, J., & Town, T. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.568212 · Cited by 51
Auderset, L., Landowski, L. M., Foa, L. C., & Young, K. M. (2016) · Stem Cells International · doi:10.1155/2016/2108495 · Cited by 51
Ohno, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.04.007 · Cited by 50
Amyloid precursor proteins are protective in Drosophila models of progressive neurodegeneration
Wentzell, J. S., Bolkan, B. J., Carmine-Simmen, K., Swanson, T. L., Musashe, D. T., & Kretzschmar, D. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.047 · Cited by 50
Beckman, M., Holsinger, R. M. D., & Small, D. H. (2006) · Biochemistry · doi:10.1021/bi052498t · Cited by 50
Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease
Martiskainen, H., Haapasalo, A., Kurkinen, K. M. A., Pihlajamäki, J., Soininen, H. S., & Hiltunen, M. O. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.789862 · Cited by 49
Novel insights into the multifaceted and tissue‐specific roles of the endocytic receptor LRP1
Yamamoto, K., Scilabra, S. D., Bonelli, S., Jensen, A., Scavenius, C., Enghild, J. J., & Strickland, D. K. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107521 · Cited by 47
Self-citationMotoki, K., Kume, H., Oda, A., Tamaoka, A., Hosaka, A., Kametani, F., & Araki, W. (2012) · Brain and Behavior · doi:10.1002/brb3.52 · Cited by 47
de Gonzalo‐Calvo, D., Cenarro, A., Martínez-Bujidos, M., Badimón, L., Bayés‐Genís, A., Ordóñez‐Llanos, J., Civeira, F., & Llorente‐Cortés, V. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.07.085 · Cited by 46
Functional interactions of APP with the apoE receptor family
Hoe, H., & Rebeck, G. W. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05517.x · Cited by 44
Leslie, P. L., Franklin, D. A., Liu, Y. U., & Zhang, Y. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.010 · Cited by 42
Klaver, D. W., Wilce, M. C. J., Cui, H., Hung, A. C., Gasperini, R., Foa, L. C., & Small, D. H. (2010) · Biological Chemistry · doi:10.1515/bc.2010.089 · Cited by 41
BACE2 plays a role in the insulin receptor trafficking in pancreatic β-cells
Casas, S., Casini, P., Piquer, S., Altirriba, J., Soty, M., Cadavez, L., Gomis, R., & Novials, A. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00420.2010 · Cited by 41
von Einem, B., Schwanzar, D., Rehn, F., Beyer, A.-S., Weber, P., Wagner, M., Schneckenburger, H., & Arnim, C. A. F. V. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.05.017 · Cited by 40
Hyman, B. (2023) · Annual Review of Medicine · doi:10.1146/annurev-med-042921-023749 · Cited by 39
Self-citationThe vascular contribution of apolipoprotein E to Alzheimer’s disease
Chen, F., Zhao, J., Meng, F., He, F., Ni, J., & Fu, Y. (2024) · Brain · doi:10.1093/brain/awae156 · Cited by 39
Regulation of BACE1 by miR-29a/b in a cellular model of Spinocerebellar ataxia 17
Roshan, R., Ghosh, T., Gadgil, M., & Pillai, B. (2012) · RNA Biology · doi:10.4161/rna.19876 · Cited by 39
Marks, N., & Berg, M. J. (2009) · Neurochemical Research · doi:10.1007/s11064-009-0054-1 · Cited by 38
Kim, D.-K., Park, J., & Choi, B. (2014) · The Journal of Toxicological Sciences · doi:10.2131/jts.39.625 · Cited by 38
Linking vascular disorders and Alzheimer's disease: Potential involvement of BACE1
Cole, S. L., & Vassar, R. J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.12.012 · Cited by 38
Boddapati, S. P., Levites, Y., & Sierks, M. R. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.10.054 · Cited by 35
The role of lipoprotein receptors on the physiological function of APP
Wagner, T., & Pietrzik, C. U. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2876-8 · Cited by 30
Emerging and potential therapies for Alzheimer's disease
Jarosz-Griffiths, H., Morten, I. J., & Hooper, N. M. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.6.693 · Cited by 30
Trafficking in neurons: Searching for new targets for Alzheimer's disease future therapies
Musardo, S., Saraceno, C., Pelucchi, S., & Marcello, E. E. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.07.019 · Cited by 29
Dafnis, I., Raftopoulou, C., Mountaki, C., Megalou, E. V., Zannis, V. I., & Chroni, A. (2018) · Biochemical Journal · doi:10.1042/bcj20180068 · Cited by 29
Emerging therapeutics for Alzheimer’s disease
Vardy, E. R. L. C., Hussain, I., & Hooper, N. M. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.5.695 · Cited by 29
Dillen, K., & Annaert, W. G. (2006) · International review of cytology · doi:10.1016/s0074-7696(06)54005-7 · Cited by 29
Is It the Twilight of BACE1 Inhibitors?
Hrabinova, M., Pejchal, J., Kucera, T., Jun, D., Schmidt, M., & Soukup, O. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200503023323 · Cited by 28
Proteomic Substrate Identification for Membrane Proteases in the Brain
Müller, S. A., Scilabra, S. D., & Lichtenthaler, S. F. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00096 · Cited by 28
Lee, Y., Lee, J. S., Lee, K. J., Turner, R. S., Hoe, H.-S., & Pak, D. T. S. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.02.027 · Cited by 27
Fan, Y., Guo, T., Han, X., Liu, J.-L., Cai, Y.-T., Han, X., Huang, X., Li, Y., Wang, Z., & Guo, C. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.07.014 · Cited by 27
Regulation of Heparan Sulfate 6-O-Sulfation by β-Secretase Activity
Nagai, N., Habuchi, H., Kitazume, S., Toyoda, H., Hashimoto, Y., & Kimata, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610691200 · Cited by 27
Garcia, J., Chang, R., Steinberg, R. A., Arce, A., Yang, J., Eb, P. V. D., Abdullah, T., Chandrashekar, D. V., Eck, S. M., Meza, P., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.930402 · Cited by 26
BACE1 regulates the proliferation and cellular functions of Schwann cells
Hu, X., Hou, H., Bastian, C., He, W., Qiu, S., Ge, Y., Yin, X., Kidd, G. J., Brunet, S., Trapp, B. D., et al. (2017) · Glia · doi:10.1002/glia.23122 · Cited by 27
Amyloid Beta Hypothesis in Alzheimer's Disease: Major Culprits and Recent Therapeutic Strategies
Dileep, K. V., & Chandra, R. (2019) · Current Drug Targets · doi:10.2174/1389450120666190806153206 · Cited by 26
LRP1 Downregulates the Alzheimer’s β-Secretase BACE1 by Modulating Its Intraneuronal Trafficking
Tanokashira, D., Motoki, K., Minegishi, S., Hosaka, A., Mamada, N., Tamaoka, A., Okada, T., Lakshmana, M. K., & Araki, W. (2015) · eNeuro · doi:10.1523/eneuro.0006-15.2015 · Cited by 25
Soluble Megalin is Reduced in Cerebrospinal Fluid Samples of Alzheimer’s Disease Patients
Spuch, C., Antequera, D., Pascual, C., Abilleira, S., Blanco, M., Moreno-Carretero, M. J., Romero-López, J., Ishida, T., Molina, J. A., Villarejo‐Galende, A., et al. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00134 · Cited by 24
Kimpe, L. D., & Scheper, W. (2009) · Current Medicinal Chemistry · doi:10.2174/092986710790149765 · Cited by 23
LRP1 Controls TNF Release via the TIMP-3/ADAM17 Axis in Endotoxin-Activated Macrophages
Schubert, K. A., Collins, L. E., Green, P. A., Nagase, H., & Troeberg, L. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800834 · Cited by 23
Depletion of Sphingolipids Facilitates Endosome to Golgi Transport of Ricin
Grimmer, S., Spilsberg, B., Hanada, K., & Sandvig, K. (2006) · Traffic · doi:10.1111/j.1600-0854.2006.00456.x · Cited by 23
Regulated Proteolysis of APP and ApoE Receptors
Hoe, H., & Rebeck, G. W. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8017-0 · Cited by 23
Regulation of amyloid-β production by the prion protein
Jarosz-Griffiths, H., Whitehouse, I. J., & Hooper, N. M. (2012) · Prion · doi:10.4161/pri.18988 · Cited by 23
Nyborg, A. C., Herl, L. D., Berezovska, O., Thomas, A. V., Ladd, T. B., Jansen, K. R., Hyman, B. T., & Golde, T. E. (2006) · Molecular Neurodegeneration · doi:10.1186/1750-1326-1-16 · Cited by 22
Self-citationTsachaki, M., Fotinopoulou, A., Slavi, N., Zarkou, V., Ghiso, J. A., & Efthimiopoulos, S. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310050009 · Cited by 21
Asynchronous Evolutionary Origins of A and BACE1
Moore, D. B., Gillentine, M. A., Botezatu, N. M., Wilson, K. A., Benson, A. E., & Langeland, J. A. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst262 · Cited by 21
Sphingolipid Metabolism and Atherosclerosis
Jiang, X., & Liu, J. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-7091-1511-4_7 · Cited by 20
Reduced Aβ secretion by human neurons under conditions of strongly increased BACE activity
Scholz, D., Chernyshova, Y., Ückert, A., & Leist, M. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14467 · Cited by 11
BACE1 Expression and Activity: Relevance in Alzheimer’s Disease
Zacchetti, D., Chieregatti, E., Bettegazzi, B., Mihailovich, M., Sousa, V. L., Grohovaz, F., & Meldolesi, J. (2007) · Neurodegenerative Diseases · doi:10.1159/000101836 · Cited by 19
C‐terminal 37 residues of LRP promote the amyloidogenic processing of APP independent of FE65
Lakshmana, M. K., Chen, E., Yoon, I., & Kang, D. E. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00320.x · Cited by 18
BACE1 Gene Promoter Single-Nucleotide Polymorphisms in Alzheimer’s Disease
Zhou, W., Cai, F., Li, Y., Yang, G., O’Connor, K. D., Holt, R. A., & Song, W. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9381-6 · Cited by 18
Soluble Receptors Affecting Stroke Outcomes: Potential Biomarkers and Therapeutic Tools
Bhattacharya, A., Ashouri, R., Fangman, M., Mazur, A., Garett, T., & Doré, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031108 · Cited by 18
Screening a series of sialyltransferases for possible BACE1 substrates
Kitazume, S., Tachida, Y., Oka, R., Nakagawa, K., Takashima, S., Lee, Y., & Hashimoto, Y. (2006) · Glycoconjugate Journal · doi:10.1007/s10719-006-6671-x · Cited by 18
Iurescia, S., Fioretti, D. P., Mangialasche, F., & Rinaldi, M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100009 · Cited by 18
Hexosaminidase A (HEXA) regulates hepatic sphingolipid and lipoprotein metabolism in mice
Montgomery, M. K., Taddese, A. Z., Bayliss, J., Nie, S., Williamson, N. A., & Watt, M. J. (2021) · The FASEB Journal · doi:10.1096/fj.202101186r · Cited by 17
Wang, R., & Lahiri, D. K. (2022) · Scientific Reports · doi:10.1038/s41598-022-05164-4 · Cited by 17
Visualizing interaction of proteins relevant to Alzheimer’s disease in intact cells
Thomas, A. V., Berezovska, O., Hyman, B. T., & Arnim, C. A. F. V. (2008) · Methods · doi:10.1016/j.ymeth.2007.02.003 · Cited by 17
Self-citationSpoelgen, R., Adams, K. W., Koker, M., Thomas, A. V., Andersen, O. M., Hallett, P. J., Bercury, K. K., Joyner, D., Deng, M., Stoothoff, W. H., et al. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.10.061 · Cited by 17
Self-citationDevelopment of a specific ELISA to measure BACE1 levels in human tissues
Gonzales, A., Decourt, B., Walker, A. W., Condjella, R. M., Nural, H. F., & Sabbagh, M. N. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.08.030 · Cited by 16
Association of ADAMDEC1 haplotype with high factor VIII levels in venous thromboembolism
Kulle, B., Luxembourg, B., Blouin, K., Spannagl, M., Lindhoff‐Last, E., Berger, M., Moscatelli, H., & Schambeck, C. M. (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-01-0059 · Cited by 15
He, P., Xin, W., Schulz, P., & Sierks, M. R. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1597-z · Cited by 14
LRP1 at the crossroads of Aβ clearance and therapeutic targeting in Alzheimer’s disease
Deng, Y., Yin, H., Lu, Z., Lan, H., Liu, W., Zuo, C., Pan, N., Tian, X., & Gong, Q. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1669405 · Cited by 13
Predicting memapsin 2 (β‐secretase) hydrolytic activity
Li, X., Huang, B., Zhang, X. C., Hartsuck, J. A., & Tang, J. (2010) · Protein Science · doi:10.1002/pro.502 · Cited by 13
Kim, J. A., Casalini, T., Brambilla, D., & Leroux, J. (2016) · Scientific Reports · doi:10.1038/srep34297 · Cited by 13
Zhao, L., Zhao, Y., Tang, F., Xiong, L., Su, C., Mei, L., Zhu, X., & Xiong, W. (2019) · Cells · doi:10.3390/cells8050474 · Cited by 13
Blood–Brain Barrier Transport of Alzheimer’s Amyloid β-Peptide
Nelson, A. R., Sagare, A. P., & Zloković, B. V. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00009-5 · Cited by 12
Splice variants of the Alzheimer’s disease beta-secretase, BACE1
Holsinger, R. M. D., Goense, N., Bohorquez, J., & Strappe, P. (2012) · Neurogenetics · doi:10.1007/s10048-012-0348-3 · Cited by 12
Turkson, V. M., Haller, A. M., Jaeschke, A., & Hui, D. Y. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.321748 · Cited by 11
Sphingomyelin biosynthesis: its impact on lipid metabolism and atherosclerosis
Jiang, X., Yeang, C., Li, Z., Chakraborty, M., Liu, J., Zhang, H., & Fan, Y. (2009) · Clinical Lipidology · doi:10.2217/clp.09.49 · Cited by 11
FXII promotes proteolytic processing of the LRP1 ectodomain
Wujak, L. A., Hesse, C., Sewald, K., Jonigk, D. D., Braubach, P., Warnecke, G., Fieguth, H., Braun, A. C., Lochnit, G., Markart, P., et al. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.05.023 · Cited by 11
Human APOER2 Isoforms Have Differential Cleavage Events and Synaptic Properties
Omuro, K. C., Gallo, C. M., Scrandis, L., Ho, A., & Beffert, U. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.1800-21.2022 · Cited by 10
Wahler, A., Beyer, A.-S., Kammerl, I. E., Schnack, C., von Einem, B., Pröpper, C., Boeckers, T. M., Peltan, I. D., Strickland, D. K., Hyman, B. T., et al. (2012) · Biochemical Journal · doi:10.1042/bj20121100 · Cited by 10
Self-citationMazura, A. D., & Pietrzik, C. U. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041268 · Cited by 9
Application of a Bioinformatics-Based Approach to Identify Novel Putative in vivo BACE1 Substrates
Johnson, J. L., Chambers, E., & Jayasundera, K. B. (2013) · Biomedical Engineering and Computational Biology · doi:10.4137/becb.s8383 · Cited by 9
Larios, J. A., & Marzolo, M.-P. (2012) · Frontiers in Biology · doi:10.1007/s11515-011-1186-7 · Cited by 9
Metadata
- Authors
- von Arnim, C. A. F., Kinoshita, A., Peltan, I. D., Tangredi, M. M., Herl, L., Lee, B. M., Spoelgen, R., Hshieh, T. T., Ranganathan, S., Battey, F. D., Liu, C.-X., Bacskai, B. J., Sever, S., Irizarry, M. C., Strickland, D. K., & Hyman, B. T.
- Affiliations
- Harvard University (US)
- Corresponding author
- Hyman, Bradley T.
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-05
- Volume
- 280
- Issue
- 18
- Pages
- 17777-17785
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2137023074
- Cited by
- 258
- References
- 50
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 5 · 2023: 2 · 2022: 6 · 2021: 7 · 2020: 3 · 2019: 7 · 2018: 6 · 2017: 12 · 2016: 11 · 2015: 11 · 2014: 12 · 2013: 19 · 2012: 24
- FWCI
- 7.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- American Federation for Aging Research
- Deutsche Forschungsgemeinschaft
- National Institutes of Health (AG15379)
- National Institute on Aging (P01AG015379, AG 12406, P50AG005134)
- National Heart, Lung, and Blood Institute (R01HL050784, P01HL054710)
- National Institute of Biomedical Imaging and Bioengineering (R01EB000768)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Keywords
- low density lipoprotein receptor-related protein, BACE1, beta-secretase, amyloid precursor protein, lipid rafts, Alzheimer's disease, amyloid-beta, endocytosis
- MeSH terms
- Animals, Cricetinae, Humans, Endopeptidases, Substrate Specificity, Aspartic Acid Endopeptidases, CHO Cells, Low Density Lipoprotein Receptor-Related Protein-1, Cell Line, Tumor, Mice, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review